阿片类镇痛药减少研究(OARS)——阿片类药物与非阿片类复方镇痛药治疗术后疼痛的比较:一项双盲随机临床试验
OARS是一项双盲、分层、多中心随机临床试验,评估非阿片类复方镇痛药(布洛芬/对乙酰氨基酚400/500 mg)是否不劣于最常处方的阿片类镇痛药(氢可酮/对乙酰氨基酚5/300 mg)用于阻生第三磨牙拔除术后疼痛管理,结局包括疼痛水平、不良事件、患者满意度、睡眠和执行日常功能能力。
要点
- OARS采用阻生第三磨牙拔除模型,因术后疼痛严重程度可预测且结果具有泛化性。
- 患者按中心和性别分层随机接受氢可酮/对乙酰氨基酚5/300 mg或布洛芬/对乙酰氨基酚400/500 mg。
- 结局包括疼痛水平、不良事件、患者满意度、睡眠和执行日常功能能力。
核心结论
- 试验旨在评估非阿片类复方镇痛药是否不劣于最常处方的阿片类镇痛药用于阻生第三磨牙拔除术后疼痛管理。
- 试验成功后,牙医、患者及其家庭将能更好地就术后疼痛管理做出知情决策。
研究设计与样本
- 双盲、分层随机、多中心临床试验。
- 在阻生第三磨牙拔除模型中进行。
- 在每个中心/诊所和性别类型(男/女)内,患者随机接受阿片类(氢可酮/对乙酰氨基酚5/300 mg)或非阿片类(布洛芬/对乙酰氨基酚400/500 mg)。
- 结局数据包括疼痛水平、不良事件、整体患者满意度、睡眠能力和执行日常功能的能力。
- 收集疼痛管理、拔牙难度和服药片数,以开发实验性决策工具。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Everyday people die unnecessarily from opioid overdose-related addiction. Dentists are among the leading prescribers of opioid analgesics. Opioid-seeking behaviors have been linked to receipt of initial opioid prescriptions following the common dental procedure of third molar extraction. With each opioid prescription, a patient's risk for opioid misuse or abuse increases. With an estimated 56 million tablets of 5 mg hydrocodone annually prescribed after third molar extractions in the USA, 3.5 million young adults may be unnecessarily exposed to opioids by dentists who are inadvertently increasing their patient's risk for addiction. METHODS: A double-blind, stratified randomized, multi-center clinical trial has been designed to evaluate whether a combination of over-the-counter non-opioid-containing analgesics is not inferior to the most prescribed opioid analgesic. The impacted 3rd molar extraction model is being used due to the predictable severity of the post-operative pain and generalizability of results. Within each site/clinic and gender type (male/female), patients are randomized to receive either OPIOID (hydrocodone/acetaminophen 5/300 mg) or NON-OPIOID (ibuprofen/acetaminophen 400/500 mg). Outcome data include pain levels, adverse events, overall patient satisfaction, ability to sleep, and ability to perform daily functions. To develop clinical guidelines and a clinical decision-making tool, pain management, extraction difficulty, and the number of tablets taken are being collected, enabling an experimental decision-making tool to be developed. DISCUSSION: The proposed methods address the shortcomings of other analgesic studies. Although prior studies have tested short-term effects of single doses of pain medications, patients and their dentists are interested in managing pain for the entire post-operative period, not just the first 12 h. After surgery, patients expect to be able to perform normal daily functions without feeling nauseous or dizzy and they desire a restful sleep at night. Parents of young people are concerned with the risks of opioid use and misuse, related either to treatments received or to subsequent use of leftover pills. Upon successful completion of this clinical trial, dentists, patients, and their families will be better able to make informed decisions regarding post-operative pain management. TRIAL REGISTRATION: ClinicalTrials.gov NCT04452344 . Registered on June 20, 2020.
引用
- Feldman CA, Fredericks-Younger J, Lu SE, et al. The Opioid Analgesic Reduction Study (OARS)-a comparison of opioid vs. non-opioid combination analgesics for management of post-surgical pain: a double-blind randomized clinical trial. Trials. 2022. PMID: 35177108. doi:10.1186/s13063-022-06064-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。